BANK OF AMERICA CORP /DE/ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,857,283
+6.2%
194,885
-2.0%
0.00%0.0%
Q2 2023$9,282,859
+4.8%
198,819
-14.1%
0.00%0.0%
Q1 2023$8,854,167
-20.2%
231,421
+14.3%
0.00%0.0%
Q4 2022$11,090,917
+363.3%
202,389
+187.8%
0.00%
Q3 2022$2,394,000
+559.5%
70,320
+82.8%
0.00%
Q2 2022$363,000
-58.9%
38,478
-38.2%
0.00%
Q1 2022$883,000
+4.9%
62,241
+56.4%
0.00%
Q4 2021$842,000
-30.3%
39,789
-26.4%
0.00%
Q3 2021$1,208,000
+456.7%
54,049
+517.7%
0.00%
Q2 2021$217,000
-29.5%
8,750
-17.7%
0.00%
Q1 2021$308,000
+58.8%
10,638
+41.2%
0.00%
Q4 2020$194,000
-80.4%
7,532
-76.6%
0.00%
Q3 2020$991,000
+348.4%
32,196
+262.8%
0.00%
Q2 2020$221,000
+281.0%
8,875
+222.8%
0.00%
Q1 2020$58,000
-56.1%
2,749
-53.9%
0.00%
Q4 2019$132,000
+187.0%
5,958
+203.8%
0.00%
Q3 2019$46,0001,9610.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders